首页> Radiation oncology (London, England)> Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?

Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?

导出 OA

翻译打印收藏纠错

第一作者： Akram,Saad

第一单位： Departments of Radiation Oncology, Chaim Sheba Medical Center, Tel Aviv University Sackler School of Medicine, Tel Hashomer, 52621, Ramat Gan, Israel.

作者： Akram,Saad ^[1] ; Jeffrey,Goldstein ^[1] ; Yaacov R,Lawrence ^[1] ; Benjamin,Spieler ^[1] ; Raya,Leibowitz-Amit ^[2] ; Raanan,Berger ^[2] ; Tima,Davidson ^[3] ; Damien,Urban ^[2] ; Lev,Tsang ^[1] ; Dror,Alezra ^[1] ; Ilana,Weiss ^[1] ; Zvi,Symon ^[4]

作者单位： Departments of Radiation Oncology, Chaim Sheba Medical Center, Tel Aviv University Sackler School of Medicine, Tel Hashomer, 52621, Ramat Gan, Israel. ^[1] Medical Oncology, Chaim Sheba Medical Center, Tel Aviv University Sackler School of Medicine, Tel-Hashomer, 52621, Israel. ^[2] Nuclear Medicine, Chaim Sheba Medical Center, Tel Aviv University Sackler School of Medicine, Tel-Hashomer, 52621, Israel. ^[3] Departments of Radiation Oncology, Chaim Sheba Medical Center, Tel Aviv University Sackler School of Medicine, Tel Hashomer, 52621, Ramat Gan, Israel. Zvi.Symon@sheba.health.gov.il. ^[4]